Currently receiving monotherapy treatment with an antiepileptic drug AED at a stable dose for at least 28 days prior to the screening visit Visit 1 If the subject is taking a barbiturate e.g. phenobarbital the dose must be stable for months prior to the Screening Visit Note Subjects who have received previous adjunctive treatment but are currently taking one AED are eligible for enrolment 